The expression of CYP1A2, CYP2B6, and CYP2C19 at mRNA level was shown to discriminate HCC from normal samples, but, ultimately, a screening test based on the protein expression level of these genes would be preferred for clinical application. Here, CYP2C19 is linked to hepatocellular carcinoma.